Droplet size distributions of nebulised aerosols for inhalation therapy.
about
Fate of aerosolized recombinant DNA-produced alpha 1-antitrypsin: use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance.Methods to identify drug deposition in the lungs following inhalationA non-bronchoconstrictor, bacteriostatic preservative for nebuliser solutionsStudy of nebulization delivery of aerosolized fluorescent microspheres to the avian respiratory tract.The effect of respiratory manoeuvres and pharmacological agents on the pharmacokinetics of nedocromil sodium after inhalationDrug delivery from jet nebulisers.Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing patternEffect of inhaled frusemide on responses of airways to bradykinin and adenosine 5'-monophosphate in asthma.Devices and formulations for pulmonary vaccination.Development of vapor deposited silica sol-gel particles for use as a bioactive materials system.Drug Delivery Devices for Inhaled Medicines.Studies using radiolabelled aerosols in children.Comparison of nebulised aerosol deposition in the lungs of healthy adults following oral and nasal inhalation.Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream").In vitro characteristics of tobramycin aerosol from ultrasonic and jet nebulizers.Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal man.A guinea pig model of acute and chronic asthma using permanently instrumented and unrestrained animals.Effect of Humidity on Constant Output and Breath Enhanced Nebulizer Designs When Tested in the EN 13544-1 EC Standard
P2860
Q33832852-430090E3-6C6F-4F02-9075-F2F8561B5D61Q34229278-1FD57AB2-65B9-4706-B277-0A81EC2288B4Q34358207-486B1CD5-A2C6-4E4D-ACF1-6457106E7012Q34362474-2969B08D-8608-4290-A245-901E4606030BQ34402996-B845623D-BAEB-4075-89B6-90E4B6B21B4CQ35628106-AFEDA831-7137-4D2F-A288-5CE242AC58B5Q36180995-E29CDC94-41A1-43DE-BE8A-FF7B497B8D85Q36566332-8DC4D592-BF33-4A5A-940D-63F038E215ADQ38115814-9F1D7C62-11DF-4A7E-8C6E-52631E02FC18Q39166641-96C9BE61-E956-4277-B586-3CDF104FF5FCQ40464067-753239A3-1DCC-4C10-B004-B93A587DC06DQ40605408-E912DEB9-61B9-4D83-B251-59208DC6676AQ41152548-5DB58F53-507A-4901-87AF-129A4313ECEBQ41233758-DBCF712F-438A-4046-A575-C14FD1E457ACQ43605168-F4AFE6BE-0C86-4379-8614-F575BBB1AE20Q45003202-4A5BEE00-651B-49DB-A041-5CD40E41EA6AQ46491859-D6E40D1B-4121-49A7-B98F-EB948177F75FQ58177630-82A4A190-6D77-4746-B380-7EAC2E600E18
P2860
Droplet size distributions of nebulised aerosols for inhalation therapy.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Droplet size distributions of nebulised aerosols for inhalation therapy.
@ast
Droplet size distributions of nebulised aerosols for inhalation therapy.
@en
type
label
Droplet size distributions of nebulised aerosols for inhalation therapy.
@ast
Droplet size distributions of nebulised aerosols for inhalation therapy.
@en
prefLabel
Droplet size distributions of nebulised aerosols for inhalation therapy.
@ast
Droplet size distributions of nebulised aerosols for inhalation therapy.
@en
P2093
P356
P1476
Droplet size distributions of nebulised aerosols for inhalation therapy.
@en
P2093
P304
P356
10.1088/0143-0815/7/2/004
P577
1986-05-01T00:00:00Z